Sling vs injection: which works best for leakage after prolapse surgery?

NCT ID NCT06754046

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two procedures—a sling or a bulkamide injection—to treat stress urinary incontinence in women who are also having vaginal prolapse repair. About 476 participants will be randomly assigned to one of the two treatments and followed for 24 months. The goal is to see which approach better reduces bothersome incontinence symptoms and has fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
bulkamide injection (PAHG) and retropubic midurethral sling (RP-MUS)
What this could lead to
If successful, this could show which procedure better reduces bothersome incontinence symptoms and has fewer complications, helping guide treatment choices for women undergoing prolapse repair.
What could go wrong
This is a mid-sized trial comparing two established procedures, so no breakthrough is expected. Results may not apply to all patients, and both procedures carry risks like infection or incomplete symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.